Research To Practice | Oncology Videos

Featuring a slide presentation and related discussion from Dr Adam Brufsky, including the following topics: Targeted therapies for HER2-expressing breast cancer (0:00) Rationale for targeting HER2-low breast cancer (6:51) Recent data with T-DXd in advanced HER2-low breast cancer (12:57) CME information and select publications

Featuring an interview with Dr Adam Brufsky, including the following topics: Trastuzumab deruxtecan (T-DXd) for HER2-low breast cancer; recently presented findings from the DESTINY-BREAST04 trial (0:00) Impact of heterogeneous disease on the detection of HER2-low expression in patients with breast cancer (7:48) Case: A woman with low-volume, asymptomatic and nonvisceral ER-positive, HER2-low breas...

Featuring perspectives from Drs Justin Gainor, Corey Langer, Luis Paz‑Ares, Heather Wakelee, Jared Weiss and Helena Yu, including the following topics: Introduction (0:00) Incorporation of immunotherapeutic strategies into the management of nonmetastatic non-small cell lung cancer (NSCLC) — Heather Wakelee, MD (3:18) Contemporary treatment for localized and metastatic NSCLC with EGFR mutations — H...

Featuring a slide presentation and related discussion from Dr Loretta Nastoupil, including the following topics: Current and emerging therapies for patients with follicular lymphoma (FL) (0:00) CAR (chimeric antigen receptor) T-cell therapy for patients with FL (10:34) Efficacy and tolerability of bispecific antibodies for patients with FL (19:6) CME information and select publications

Featuring an interview with Dr Loretta Nastoupil, including the following topics: Impact of COVID-19 on the management of follicular lymphoma (FL) (0:00) Case: A woman in her late 50s with Grade IIIA symptomatic FL (3:48) Case: A man in his early 70s with low-grade FL and asymptomatic adenopathy 6 years after a complete response (8:21) Case: A patient with heavily pretreated relapsed/refractory FL...

Featuring perspectives from Drs Yohann Loriot, Elizabeth Plimack and Jonathan Rosenberg, including the following topics: Introduction (0:00) Current and Future Management of Localized Urothelial Bladder Cancer (UBC) (2:59) First-Line Treatment for Patients with Metastatic UBC (mUBC) (28:29) Later-Line Therapeutic Options for Patients with mUBC: Novel Investigational Strategies (47:08) CME informat...

Featuring perspectives from Drs Ian Flinn, Brian Hill, John Leonard, Matthew Lunning, Laurie Sehn and Mitchell Smith, including the following topics: Introduction (0:00) Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) — Ian W Flinn, MD, PhD (3:07) Relapsed/Refractory CLL; Novel Investigational Strategies — Mitchell R Smith, MD, PhD (32:31) Treatment for Follicular Lymphoma — John P Leonard, MD...

Featuring perspectives from Drs Javier Cortés, Matthew Goetz, Erika Hamilton, Ian Krop, Hope Rugo and Sara Tolaney, including the following topics: Introduction (0:00) Optimizing the Management of ER-Positive Localized Breast Cancer — Matthew P Goetz, MD (7:50) New and Novel Treatment Strategies for Localized Triple-Negative Breast Cancer (TNBC) — Erika Hamilton, MD (38:35) Considerations in the C...

Featuring perspectives from Drs Tanios Bekaii-Saab, Kristen Ciombor, Eileen O'Reilly, Philip Philip, John Strickler and Prof Eric Van Cutsem, including the following topics: Introduction (0:00) Integration of targeted therapy and immunotherapy into the management of metastatic colorectal cancer — Kristen K Ciombor, MD, MSCI (3:15) Other considerations in the management of early and advanced colore...

Featuring perspectives from Ms Paula Anastasia, Dr Robert Coleman, Dr David O'Malley and Ms Jaclyn Shaver, including the following topics: Introduction (0:00) Management of Endometrial Cancer (5:32) Treatment for Cervical Cancer (45:31) COVID-19: Considerations in Cervical and Endometrial Cancer (1:22:34) Oncology 2032 Crystal Ball (1:27:43) CME information and select publications

Featuring perspectives from Drs Antonio González-Martín, Joyce Liu and Kathleen Moore, including the following topics: Introduction (0:00) Clinical Management of Advanced Ovarian Cancer (2:23) Novel Treatments and Strategies Under Investigation (46:04) CME information and select publications

Featuring perspectives from Drs Andrew Armstrong, Alan Bryce and Alicia Morgans, including the following topics: Introduction (0:00) Case: A man in his early 70s with DIPSS low- to intermediate-risk post-essential thrombocythemia myelofibrosis (MF) — Warren S Brenner, MD (5:29) Case: A woman in her late 60s with primary MF who experiences disease progression after 3 years of ruxolitinib — Jeanne P...

Featuring perspectives from Prof Harry Yoon, including the following topics: Introduction (0:00) Case: A woman in her late 30s with Stage IIIA HER2-negative adenocarcinoma of the gastric antrum (pMMR, PD-L1 CPS

Featuring perspectives from Drs Courtney DiNardo, Michael Savona and Eunice Wang, including the following topics: Introduction (0:00) Selection of therapy for older and younger patients with acute myeloid leukemia (AML) (2:05) Therapy for patients with AML with targetable mutations (33:42) Current and future management of myelodysplastic syndromes (49:04) CME information and select publications

Featuring perspectives from Dr Kristen Ciombor and Ms Jessica Mitchell, including the following topics: Introduction (0:00) Management of localized disease (10:56) Management of HER2-negative metastatic disease (34:36) Management of HER2-positive metastatic disease (57:08) NCPD information and select publications

Featuring perspectives from Dr John Mascarenhas, including the following topics: Introduction (0:00) Case: A man in his mid 60s with post-PV myelofibrosis (MF) and ASXL1 and SRSF2 mutations — Jeanne Palmer, MD (22:40) Case: A woman in her early 70s with high-risk primary MF and a CALR mutation (28:34) Case: A woman in her mid 70s with primary MF with a JAK2 V617F mutation — Bhavana (Tina) Bhatnaga...

Featuring perspectives from Ms Lesley Camille Ballance, Ms Amy Goodrich, Dr Lowell Hart and Dr Anthony Mato, including the following topics: Introduction (0:00) Overview of Chronic Lymphocytic Leukemia (5:47) Bruton Tyrosine Kinase Inhibitors (27:40) Venetoclax and Anti-CD20 Antibody Therapy (58:59) Future Strategies (1:15:51) NCPD information and select publications

Featuring perspectives from Ms Monica Averia, Dr Shilpa Gupta, Ms Brenda Martone and Dr Sumanta Kumar Pal, including the following topics: Introduction (0:00) Management of Localized Urothelial Bladder Cancer (UBC): Adjuvant Treatment, TAR-200 (6:47) Management of Metastatic UBC: Antibody-Drug Conjugates, Checkpoint Inhibitors (33:00) Management of UBC with an FGFR Mutation (57:37) Oncology/UBC 20...

Featuring perspectives from Ms Ilene Galinsky and Dr Eunice Wang, including the following topics: Introduction (0:00) Younger patients with acute myeloid leukemia (AML) (2:11) Older patients with AML (34:45) Treatment for myelodysplastic syndromes (49:57) NCPD information and select publications

Featuring perspectives from Dr Susan O'Brien, including the following topics: Introduction (0:00) Case: A woman in her mid 60s with relapsed Chronic Lymphocytic Leukemia (CLL) who experiences severe headaches on acalabrutinib — Bhavana (Tina) Bhatnagar, DO (12:57) Case: A man in his early 70s with IGHV-unmutated relapsed CLL — Gurveen Kaur, MD (24:43) Case: A man in his late 60s with chronic kidne...

Featuring perspectives from Ms Marianne Davies, Dr Matthew Gubens, Dr Lowell Hart and Ms Chaely Medley, including the following topics: Introduction (0:00) Overview of Small Cell Lung Cancer (SCLC) (6:42) First-line Therapy and Prevention of Cytopenias (25:03) Second Line and Beyond (1:04:33) SVC (Superior Vena Cava), SIADH (Syndrome of Inappropriate Antidiuretic Hormone) and Other Paraneoplastic...

Featuring perspectives from Dr Richard Finn and Ms Amanda Wagner, including the following topics: Introduction (0:00) First-line Treatment of Hepatocellular Cancer (HCC) (2:28) Management of Recurrent HCC (26:57) Treatment of Biliary Tract Cancers (33:39) NCPD information and select publications

Featuring a slide presentation and related discussion from Dr Brian Rini on the role of immunotherapy in nonmetastatic renal cell carcinoma and considerations for disease management in special patient populations. CME information and select publications

Featuring perspectives from Drs Thomas Hutson and Brian Rini, including the following topics: Introduction — Common Questions in the Management of Renal Cell Carcinoma (0:00) Adjuvant Immunotherapy (11:26) First-Line Treatment of Metastatic Disease (27:00) Management of Relapsed/Refractory Disease (38:25) Treatment with Belzutifan (47:35) CME information and select publications

A clinical investigator think tank and enduring multimedia activity with Drs Naval Daver, Stephen Strickland, Geoffrey Uy and Eunice Wang, including the following topics: Introduction to therapy-related Acute Myeloid Leukemia (AML) (0:00) Treatment of AML evolving from prior MDS (12:27) Treatment of secondary AML in a patient ineligible for intensive therapy (29:41) Treatment for a patient with se...